Alexandra Wagner, PhD

Technophage, Investigação e Desenvolvimento em Biotecnologia S.A., Portugal

Disclosure(s): No financial relationships to disclose

Poster(s):

• 1690 - Assessing the safety of TP-102 bacteriophage treatment in the management of diabetic foot infections
  Saturday, October 22, 2022

  12:15 PM – 1:30 PM US ET